KLOW Peptide Blend – 80mg Research Compound

KLOW peptide blend is a multi-component research formulation combining four individually identified research peptides in a single 80mg multidose vial. The formulation contains BPC-157, GHK-Cu, TB-500, and KPV and is supplied as a lyophilized powder for laboratory and scientific research applications.

The KLOW research peptide formulation is designed for researchers studying peptide composition, molecular interactions, cellular signaling, extracellular matrix biology, and related biochemical pathways. Each component contributes a distinct research subject, allowing laboratories to investigate the characteristics and interactions of multiple peptides within a defined formulation.

Product Specifications

• Product: KLOW Blend
• Total Strength: 80 mg
• BPC-157: 10 mg
• GHK-Cu: 50 mg
• TB-500: 10 mg
• KPV: 10 mg
• Purity: ≥99%
• Format: Multidose Vial
• Grade: Research Grade
• Appearance: Lyophilized powder
• Storage: Store refrigerated at 2°C–8°C. Protect from light and moisture.

The listed composition provides a total of 80mg of research compound material. Researchers should refer to the applicable product documentation and available Certificate of Analysis (COA) for batch-specific information.

KLOW Peptide Blend Composition

The KLOW 80mg formulation combines four research peptides:

BPC-157 – 10mg

BPC-157 is included as one component of this four-peptide research blend. It has been investigated in preclinical research models involving cellular and molecular pathways.

GHK-Cu – 50mg

GHK-Cu is the largest component of the KLOW formulation at 50mg. This copper-containing peptide is investigated in laboratory research involving cellular communication, extracellular matrix biology, and related biochemical processes.

TB-500 – 10mg

TB-500 is included at 10mg. Research involving TB-500 and related thymosin-beta-4 pathways has examined areas including cellular processes, tissue biology, and molecular signaling.

For researchers interested in studying the individual compound separately, BioMatrix Compounds also offers [TB-500 10mg] as an individual research product.

KPV – 10mg

KPV completes the four-component formulation at 10mg. KPV is investigated in laboratory settings involving peptide interactions, cellular signaling, and molecular research.

Research Applications

The KLOW research peptide blend may be used as a research material in controlled laboratory investigations involving:

• Cellular signaling and communication
• Extracellular matrix biology
• Peptide interaction studies
• Molecular and biochemical research
• Cellular response pathways
• Tissue biology research
• Inflammatory signaling pathways
• Comparative peptide research
• Multi-peptide formulation studies

These research areas describe laboratory applications and research subjects rather than established medical or therapeutic uses. The individual components of KLOW have been investigated in scientific literature and preclinical models, but findings from individual peptides should not be interpreted as evidence that the combined KLOW formulation produces a particular clinical effect. A recent peer-reviewed scoping review, for example, notes that evidence surrounding several emerging peptides remains limited and varies considerably by compound and research model.

KLOW 80mg Research-Grade Format

The KLOW 80mg research compound is supplied as a lyophilized powder in a multidose vial. Its defined four-component composition provides researchers with a consistent formulation for laboratory investigation.

BioMatrix Compounds emphasizes product information, quality, consistency, and transparency. Supporting documentation, including Certificates of Analysis where available, can provide additional batch-specific information for researchers evaluating a research compound.

Researchers should review the applicable product documentation before incorporating any material into laboratory protocols and should maintain appropriate laboratory handling, storage, and documentation procedures.

Quality and Storage

KLOW peptide blend is listed as ≥99% purity and supplied in research-grade format. The lyophilized material should be stored refrigerated at 2°C–8°C and protected from light and moisture according to the product specifications.

Proper storage helps maintain the stated product specifications during the intended research lifecycle. Always refer to the applicable product documentation for current handling and storage information.

Research Use Only

KLOW peptide blend is intended exclusively for laboratory and scientific research purposes.

This product is not intended for human consumption, veterinary use, medical use, therapeutic use, cosmetic use, food use, or diagnostic applications. It is not represented as a drug, treatment, or therapeutic product.

Health Canada has issued public advisories concerning unauthorized injectable peptide products, including several compounds that are also components of research formulations such as BPC-157, GHK-Cu, KPV, and TB-500. Canadian customers should review applicable federal, provincial, and local requirements before purchasing, possessing, handling, or using any research compound.

For Canadian regulatory information, researchers can review the relevant Health Canada advisory on unauthorized injectable peptide drugs.

By purchasing KLOW peptide blend from BioMatrix Compounds, customers acknowledge that the product is supplied for legitimate laboratory research purposes and accept responsibility for ensuring that its purchase, possession, handling, storage, and research use comply with all applicable laws and regulations.

For Research Use Only. Not for Human or Veterinary Use.